# Interim analysis of post-marketing surveillance of eculizumab for paroxysmal nocturnal hemoglobinuria in Japan

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/interim-analysis-of-post-marketing-surveillance-of-eculizumab-for-paroxysmal/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Haruhiko Ninomiya,Naoshi Obara,Shigeru Chiba,Kensuke Usuki,Kaichi Nishiwaki,Itaru Matsumura,Tsutomu Shichishima,Shinichiro Okamoto,J Nishimura,Kazuma Ohyashiki,Shinji Nakao,Kiyoshi Ando,Yoshinobu Kanda,Tatsuya Kawaguchi,Hideki Nakakuma,Daisuke Harada,H Akiyama,Taroh Kinoshita,Keiya Ozawa,Mitsuhiro Omine,Yuzuru Kanakura |
| Citations | 31 |
| DOI | 10.1007/s12185-016-2065-4 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2493998604 |
| PMID | 27464489 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Shigeru Chiba](https://scholariq.org/researchers/shigeru-chiba/)
- [Yoshinobu Kanda](https://scholariq.org/researchers/yoshinobu-kanda/)
- [Taroh Kinoshita](https://scholariq.org/researchers/taroh-kinoshita/)
- [Keiya Ozawa](https://scholariq.org/researchers/keiya-ozawa/)
- [Yuzuru Kanakura](https://scholariq.org/researchers/yuzuru-kanakura/)

## Paper journal

- [International Journal of Hematology](https://scholariq.org/journals/international-journal-of-hematology/)

## Paper primary topic

- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)

## Paper topics

- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Coagulation, Bradykinin, Polyphosphates, and Angioedema](https://scholariq.org/topics/coagulation-bradykinin-polyphosphates-and-angioedema/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.